190 related articles for article (PubMed ID: 18622261)
1. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene.
Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ
Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261
[TBL] [Abstract][Full Text] [Related]
2. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants.
Ménard V; Eap O; Roberge J; Harvey M; Lévesque E; Guillemette C
Pharmacogenet Genomics; 2011 Oct; 21(10):631-41. PubMed ID: 21881541
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.
Saeki M; Saito Y; Jinno H; Tanaka-Kagawa T; Ohno A; Ozawa S; Ueno K; Kamakura S; Kamatani N; Komamura K; Kitakaze M; Sawada J
Drug Metab Dispos; 2004 Sep; 32(9):1048-54. PubMed ID: 15319348
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population.
Hwang MS; Lee SJ; Jeong HE; Lee S; Yoo MA; Shin JG
Drug Metab Pharmacokinet; 2010; 25(4):398-402. PubMed ID: 20814162
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
[TBL] [Abstract][Full Text] [Related]
7. A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity.
Duguay Y; Báár C; Skorpen F; Guillemette C
Clin Pharmacol Ther; 2004 Mar; 75(3):223-33. PubMed ID: 15001974
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
9. Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects.
Saito K; Moriya H; Sawaguchi T; Hayakawa T; Nakahara S; Goto A; Arimura Y; Imai K; Kurosawa N; Owada E; Miyamoto A
Clin Biochem; 2006 Mar; 39(3):303-8. PubMed ID: 16466707
[TBL] [Abstract][Full Text] [Related]
10. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter.
Hu DG; Meech R; Lu L; McKinnon RA; Mackenzie PI
Drug Metab Dispos; 2014 May; 42(5):854-62. PubMed ID: 24561451
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity.
Jones NR; Sun D; Freeman WM; Lazarus P
J Pharmacol Exp Ther; 2012 Sep; 342(3):720-9. PubMed ID: 22661630
[TBL] [Abstract][Full Text] [Related]
14. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
[TBL] [Abstract][Full Text] [Related]
15. Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy.
Hirota T; Ieiri I; Takane H; Sano H; Kawamoto K; Aono H; Yamasaki A; Takeuchi H; Masada M; Shimizu E; Higuchi S; Otsubo K
Drug Metab Dispos; 2003 May; 31(5):677-80. PubMed ID: 12695358
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.
Bhasker CR; McKinnon W; Stone A; Lo AC; Kubota T; Ishizaki T; Miners JO
Pharmacogenetics; 2000 Nov; 10(8):679-85. PubMed ID: 11186130
[TBL] [Abstract][Full Text] [Related]
17. Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
Bernard O; Tojcic J; Journault K; Perusse L; Guillemette C
Drug Metab Dispos; 2006 Sep; 34(9):1539-45. PubMed ID: 16790554
[TBL] [Abstract][Full Text] [Related]
18. The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.
Yang ZZ; Li L; Wang L; Yuan LM; Xu MC; Gu JK; Jiang HD; Yu LS; Zeng S
Acta Pharmacol Sin; 2017 Aug; 38(8):1184-1194. PubMed ID: 28552915
[TBL] [Abstract][Full Text] [Related]
19. Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.
Stone AN; Mackenzie PI; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2003 Sep; 31(9):1086-9. PubMed ID: 12920162
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor-1alpha is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers.
Toide K; Takahashi Y; Yamazaki H; Terauchi Y; Fujii T; Parkinson A; Kamataki T
Drug Metab Dispos; 2002 Jun; 30(6):613-5. PubMed ID: 12019184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
